One of the first Advisors to The Triana Group in 2009, Tamar Howson is a Member of Board for several life sciences companies and investment groups. A former Senior Vice President for Corporate and Business Development at Bristol Myers Squibb, overseeing M&A, licensing, and research collaborations across all business sectors. She was also the Director of Worldwide Business and Corporate Development at SmithKline Beecham, and the former Manager of SR One, SmithKline Beecham’s $100 million corporate venture fund. Her current and past Board of Directors memberships include Ariad Pharmaceuticals, NPS Pharmaceuticals, SkyePharma Plc., Targacept, and Bioline Rx.
Tamar holds a MBA from Columbia U., MS from CCNY and BS in Chem. E. from the Technion, Israel. She is a Healthcare Business Women Association Woman of the Year.[back]